Brief: Oncocyte Announces The Clinical Launch Of DetermaIO Immunotherapy Response Prediction Test
04/11/2021 13:14
Nov 4 (Reuters) - OncoCyte Corp OCX.O :
* ONCOCYTE ANNOUNCES THE CLINICAL LAUNCH OF DETERMAIO
IMMUNOTHERAPY RESPONSE PREDICTION TEST
Source text for Eikon: ID:nGNXWLQS2
Further company coverage: OCX.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Insight Molecular Diagnostics
See all newsBrief: Insight Molecular Diagnostics Enters Amendment No. 2 To Merger Agreement On Sept 15, 2026
Insight Molecular Diagnostics Inc reports results for the quarter ended June 30 - Earnings Summary
Insight Molecular Diagnostics Inc expected to post a loss of 24 cents a share - Earnings Preview
Insight Molecular Diagnostics Q1 loss narrows as costs drop
Brief: Insight Molecular Diagnostics Completes Key Milestones Advancing Graftassuredx Toward FDA Submission